chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I notice 2 weeks after the vaccine, I started having loose BM, 3 to 5 times a week with loose BM, and then I go a week without any bowl movements. I also started to notice hair loss 2 weeks after the vaccination. I lost a lot of hair for like 2 to 3 days and now it's back to normal. I spoke to doctors and they said they have been seeing a lot of aftermath symptoms, many different side effects after the vaccine. The doctors told me to eat a diet with high fibers, if I'm constipated, and fruits and vegetables. And to take a laxative as needed.  If I go without a BM for 5 day, I stick to only liquids. I'm still struggling with the constipation.
20cm around arm, width, 21 1/2 cm in length. Red, hot, swollen left arm.
unconsolable crying on & off until 6PM had dinner threw up 630PM;6x in next hr;lethargic, limp, dead to world about 8PM called MD-examined dehydrated started to wake up;no further vomit;had quarter size redness x 2wk;
Left arm solid very red rash, swollen, raised hot to touch, painful to touch, arm sore. No symptoms until day 7 after shot. Lasted just over 24 hours. No other symptoms. No treatment pursued.
She got her vaccine, halfway through the 15 minute waiting period she had a rushing sensation, like something was rushing into her blood stream, going up to the left side of her face. She had between the eye, ear and chin something that felt different, a numbness or tingling in that area.  She then went outside and walked around and felt kind of wound up but glad that she was doing well.  Then driving back home she had a sharp pain in her heart area, maybe up the arm on the left side where she did not have the shot.  Then she was disoriented, was holding onto a tree to get grounded once she got home.  She had the feeling that she was not fully in her body, this went on for about 2-3 days.  She would drive and feel that she was behind her body.  She also had tinnitus in the left ear, which she has had ever since the vaccine.  She did not have tinnitus prior to the vaccine.  She woke up the 2nd day with the feeling of doom, something was not right feeling.  She later in the month of it wearing out she had a sebaceous type of skin rash that she had never had which did go away after several months.  She has since seen some presentation on some medical students who were on the opening trials found out that these were symptoms of that.  She then found out that there were people who had problems in the face area like Bell's palsy, odd sensations with sounds and sight, and she felt lucky that it was not more severe.  She did get the 2nd vaccine, and has not gotten any boosters, she has talked to her doctor regarding this.  She only had a fever and chills with the 2nd vaccine.  She was concerned that they did not aspirate before giving the vaccine thinking that it got more into her blood stream than in just the muscle.  It is outlawed in Denmark and Sweden not to aspirate first.    She still has tinnitus that she did not have before.  She got better and was hesitant to do boosters.
I thought it was allergies. I had a very runny nose and itchy eyes. I was with some people last weekend and one person tested positive for COVID-19. I took a COVID-19 home test and tested positive. Then, I went to a clinic and tested positive there. They gave me PAXLOVD. I'm on the 4th day of that.
Patient developed scattered papular lesions over body and extremities on 7/25/14 - along with diarrhea - parents concerned may have been immunization reaction.
Combo of MMR and Varicella 0975F (ProQuad) SQ in right thigh, pt had swelling of entire right thigh warm to touch but no redness or fever.
I was whether dizzy, nothing real bad but dizzy; fuzzy head and dizzy; I take blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad; I was whether dizzy, nothing real bad but dizzy; fuzzy head and dizzy; I take blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A  patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 12Aug2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "blood pressure" (unspecified if ongoing), notes: I take blood pressure medicine and one water pill (Unspecified Medication). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose.), for Covid-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 13Aug2021, outcome "unknown", DIZZINESS (non-serious) with onset 13Aug2021, outcome "recovered" and all described as "I was whether dizzy, nothing real bad but dizzy; fuzzy head and dizzy; I take blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad".  Additional Information: Consumer queried if the patient  took the 2nd Pfizer shot yesterday at (withheld) today, IT was whether dizzy, nothing real bad but dizzy. But had developed now in last couple of hours, may be in a hour fuzzy head and dizzy and now the patient took blood pressure medicine and one water pill (Unspecified Medication), both of these pills make me little dizzy not bad and the patient won-dered if one needs to  wait more to take the water pill and blood pressure pill or what. All the pa-tient wanted was the answer if the the blood pressure pill or water pill should be taken today, even though Pfizer shot got one dizzy and now the patient is not dizzy anymore. The LOT number was reported: FC3180.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe vertigo; Dizziness; This case was reported by a consumer and described the occurrence of vertigo in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced vertigo and dizziness. On an unknown date, the outcome of the vertigo and dizziness were unknown.   It was unknown if the reporter considered the vertigo and dizziness to be related to Shingrix.  Additional details were provided as follows: This case was reported by the reporter for an unspecified number of patients. The age at vaccination was not applicable for this report. The reporter saw a new ENT specialist, who stated her that he had seen a couple of patients with severe vertigo and dizziness after Shingrix which is similar to her experience. This case linked with US2019AMR176889 and US2019AMR176896, reported by same reporter.
vasculitis; twin also experienced similar symptoms of GI; This case was reported by a physician via sales rep and described the occurrence of gastrointestinal disorder in a 6-year-old patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   The patient's past medical history included premature birth (patient was born 6 weeks premature).   On 16th October 2020, the patient received Fluarix Quadrivalent 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 26th October 2020, 10 days after receiving Fluarix Quadrivalent 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced gastrointestinal disorder. On 29th October 2020, the patient experienced vasculitis. On an unknown date, the outcome of the gastrointestinal disorder and vasculitis were unknown.   It was unknown if the reporter considered the gastrointestinal disorder and vasculitis to be related to Fluarix Quadrivalent 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient developed gastrointestinal symptoms and vasculitis but did not seen by the doctor as the mother did brought only twin to the doctor's office. The patient's twin also experienced similar symptoms of gastrointestinal symptoms and vasculitis (refer case US2021AMR022024). The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR047386:same reporter US-GLAXOSMITHKLINE-US2021AMR022024:twin´s case
On 1/13/15 the patient states he started to experience bilateral hand tremors, patient dropped one thing, and he had to really concentrate to bring a cup to his mouth or utensils.  He also had joint pain, fever and diaphoresis.  He took Tylenol which help alleviate his symptoms. Site Reaction was noted on the right upper extremity on the distal/medial and latter portion of the arm.  The site was red, warm and painful to touch.
Patient was given incorrect vaccine/dose. Patient was given the Pediatric Pfizer for ages 5-11 years old. The patient is 12 years old and should have received the Pfizer age 12 and up.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 20-MAY-2015 the patient was vaccinated with a dose of PROQUAD (Merck), lot # L003221, expiration date 30-JUL-2016 (dose and route not reported), which was improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Had an unexpected and unusual localized reaction to the PPD test. Symptoms included increased erythema, tenderness, and a nodule (6mm). It is suspected that a 0.1 ml of anthrax vaccine was erroneously administered to the sm instead of the standard PPD solution.
Dizziness and nausea within five minutes after injections. Fever 103.7
tightness of shoulders and neck; tightness of shoulders and neck; started having severe nausea in the last hour; Has a slight headache; This is a spontaneous report from a contactable consumer (patient herself). A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 08:00 in left arm at single dose for covid-19 immunization.  Medical history included ongoing diabetes (she had it for 20 years), ongoing asthma (she had it for 25 years), ongoing cirrhosis of the liver non alcoholi diagnosed two years ago, ongoing hypertension diagnosed in the last three months, ongoing fatty liver diagnosed two years ago. There were no concomitant medications. Patient had Covid vaccine this morning at 8 am (12Jan2021) that was fine after 15 minutes, but patient started having severe nausea in the last hour and was unresolved by her nausea medicine. Patient had a slight headache. Patient stated that the headache which was mild, tightness of shoulders and neck started at 13:30. Patient stated that she took acetaminophen 1000 units and used a heating pad for the shoulder. Outcome of nausea was not recovered, and outcome of events were recovered on 12Jan2021.   Information on the lot/batch number has been requested.
I had the first Shingles vaccine on 06/14/2023 at the hospital here. I got a terrible reaction in my arm and it swelled up to about double size and was red, hot and very painful. Almost exactly 72 hours after receiving the vaccine I had a stroke. I lost speech and was unable to stand up and my wife called the ambulance. I have a Watchman device and am not supposed to get blood clots and they did not find any clots on 2 scans at the hospital, one without contrast and one with contrast. They did give me the TNK after a video conference with a neurologist. My speech started to return in about an hour and by the next day I was normal with speech. My wife feels I may have some residual memory issues. I have heard that inflammation can cause a stroke and I feel the inflammation from the vaccine caused mine. I saw a neurologist at the Hospital where I go for my cardiology and he calls it an "event" as I am unable to have an MRI due to my pacemaker. I will not be getting the second shot for the shingles vaccine.
Elevated heart rate, twitching, tingling, numbness, insomnia, anxiety, flu like symptoms, brain fog, troubling swallowing food, inability to walk, fatigue, exhaustion, inability to work, inability to drive, pain everywhere
cancer; decreased immune system; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team, Program ID.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Bnt162b2 for Covid-19 Vaccination, notes: primary series of Pfizer Covid-19 vaccine gray cap, Dose 1 and 2. The following information was reported: NEOPLASM MALIGNANT (medically significant), outcome "unknown", described as "cancer"; DECREASED IMMUNE RESPONSIVENESS (non-serious), outcome "unknown", described as "decreased immune system".  Clinical course: Warm transfer from [Name withheld] with Support, with a Pharmacist on the line who has a question regarding restarting a series due to cancer for the Pfizer Covid-19 Vaccine, gray cap. The patient received the primary series of Pfizer Covid-19 vaccine gray cap and booster dose. The doctor wants the patient to restart the series.Caller verified information provided. As far as she knows, there was no issue with the patient receiving the vaccines. Pfizer Covid-19 Vaccine: Additional Lots/NDCs/Expiries: Not provided, caller unwilling to complete the report, Booster dose Lot/NDC/Expiry: Not provided, caller unwilling to complete the report. Looks like the doctor's office has a patient with cancer with decreased immune system and wanted to restart the series. Didn't see anything in the CDC guidance  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information currently available "NEOPLASM MALIGNANT " considered most likely associated with intercurrent or underlying medical conditions, appears unrelated to suspect drug . The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Tightness on L side of neck approx 10 min after vaccine. Denies SOB/dizziness/CP. Stable and released.
Diluent was drew up by 0.8ml instead of 1.8ml and mixed with Pfizer vial.
A few minutes after receiving immunizations client fell from chair onto her knees. She was assisted back into the chair. At that time she said she felt nauseous. She was assisted to the bathroom per her request. Vitals taken and were normal. Client stated she has a history of fainting and fear of needles. No visible injuries and denied pain. Followed up w/a phone call at 4:00pm. Client stated she felt fine.
Systemic: Fainting / Unresponsive-Mild, Systemic: Hypotension-Mild, Additional Details: Patient prone to fainting, sweaty, pale face. Laid patient down, lifted knees. Mother was with patient, denied emergency care. Patient recovered and was able to walk out of pharmacy unassisted after event.
pt recv vax & 1yr p/vax pt devel approx 40 lesions on torso, face, & limbs;
Breakthrough case admission after 4 vaccines Pfizer 3/3/21 lot# EN6205;  Pfizer 3/24/21 lot# EN6204;  Pfizer 8/16/21 lot# FK9895;  Pfizer 3/30/22 lot# FK9895
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 10/01/2021. PATIENT FULLY VACCINATED ON 03/09/2021.
Depression aggravated; Exacerbation of anxiety; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (Depression aggravated) and ANXIETY (Exacerbation of anxiety) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) solution for injection for Plaque psoriasis.    No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In June 2021, the patient experienced DEPRESSION (Depression aggravated) and ANXIETY (Exacerbation of anxiety). At the time of the report, DEPRESSION (Depression aggravated) and ANXIETY (Exacerbation of anxiety) was resolving.            Patient had an exacerbation of her anxiety and depression over some events at work over the past couple months in Jun-2021 and had begun Electrical stimulation therapy.  No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-624133 (Patient Link).
Initial and follow-up information has been received from a health professional and a consumer concerning a 53 day old female who on 03-DEC-2007 was vaccinated IM in the right thigh with her first dose of TRIPEDIA (lot C2797AA), vaccinated with the first dose of ROTATEQ oral (MSD; lot #6576699/1393U), and IM in the left thigh with a dose of IPOL (lot #A0301) and PREVNAR(lot # #B54013E). On 03-DEC-2007, the patient developed a fever and was throwing up. Unspecified medical attention was sought. The patient's fever and vomiting persisted. No additional information is expected.
Vomiting, chills, headache, fever, back pain the next day. Vomiting, headache, severe back pain day 3
Shingle Shot was administered and three hours later I experienced... Poor co-ordination.  Tripped getting out of a car and tripped again when I tried to lift my leg to step up on the curb and fell.  I was not hurt because I fell on the grass slowly after I tripped.  I experienced Dizziness, heart palpatations, and a slight headache.  Heart palpations stopped after about 60 seconds.  Dizziness lasted for about 20 minutes and slight headache lasted for a few hours.
fever of 100.3; chills; body aches; runny nose; sinus drainage; This is a spontaneous report from a contactable consumer (patient). A 45-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number was not reported), via an unspecified route of administration on an unspecified date (age at time of vaccination 45 years) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medication included vitamins number (VITAMINS NOS), fish oil (FISH OIL), vitamin D [vitamin d nos] (VITAMIN D [VITAMIN D NOS]), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) and zinc (ZINC) all taken for an unspecified indication, start and stop date were not reported. The patient developed fever of 100.3, chills, body aches, runny nose and sinus drainage on an unspecified date. The events were assessed as non-serious. Event was around 12 hrs after vaccine administration. Event took place after use of product. The patient underwent lab tests and procedures which included body temperature: 100.3 on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
Chronic headache beginning the day after AVA #9. Multiple visits for evaluation and treatment. Controlled on meds.
This spontaneous report was received from a physician via a company representative and refers to twelve patients of unknown age and gender. No information regarding the patients' pertinent medical histories, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with doses of ZOSTAVAX (19400 plaque-forming units) (dose, route of administration, lot # and expiry date were not reported) for prevention of shingles. Other suspect therapies included sterile diluent. On unknown dates, the patients experienced shingles. The physician reported that these were "wild-type shingles, not vaccine-type shingles". The physician did not believe that ZOSTAVAX was effective in preventing wild-type shingles. Action taken with the suspect therapies, the outcome of the events and the relatedness between the events and suspect therapies were not reported. Additional information is not expected as there was no consent to contact the physician.
Erythema to injection site 4 inches long x 2 inches wide. Warm to touch lasted 72 hours. Treated with Benadryl PO and topically.